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Porphobilinogen deaminase isolated from Escherichia coli is shown to contain a dipyrromethane cofactor 
(DPMC) linked covalently to the enzyme. The structure of the cofactor is proposed on the basis of its reac- 
tion with Ehrlich’s reagent and from its chemical properties. The cofactor is involved in the binding of inter- 
mediates during the catalytic reaction but is not incorporated into the product preuroporphyrinogen, E. 
coli strains containing the cloned porphobilinogen deaminase gene (hemC) when grown on 5-amino[‘4C]- 
levulinic acid incorporate 14C radioactivity specifically into the dipyrromethane cofactor of porphobilinogen 
deaminase. 
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1. INTRODUCTION 
Porphobilinogen deaminase (hydroxymethylbi- 
lane synthase, EC 4.3.1.8) catalyses the tetrapoly- 
merization of the pyrrole porphobilinogen (1) to 
yield the unstable hydroxymethylbilane, 
preuroporphyrinogen (2) [ 1,2]. Uroporphyrinogen 
III synthase subsequently catalyses the isomeriza- 
tion and cyclization of the preuroporphyrinogen to 
uroporphyrinogen III (3) [3], the key precursor for 
heme, chlorophyll and all other tetrapyrroles. In 
the absence of the synthase, preuroporphyrinogen 
cyclizes chemically to give uroporphyrinogen I (4) 
[3,41. 
The deaminases from a wide variety of sources 
have been purified to homogeneity and all appear 
to be monomeric enzymes with an A4, ranging from 
34000 to 44000. More recently the cloning and se- 
quencing of the gene coding for E. coli por- 
phobilinogen deaminase (hemC’) has been reported 
[S]. The application of molecular cloning has also 
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resulted in the generation of E. coli strains which 
produce almost 100 times the wild type deaminase 
levels [6]. 
One of the most striking properties of the por- 
phobilinogen deaminases is their ability to form 
stable enzyme intermediate complexes with one, 
two, three or four pyrrole units bound to the 
catalytic site [7,8]. Single turnover experiments 
with labelled substrate have shown that the first 
porphobilinogen molecule to bind at the active site 
is destined to become ring a in the preuropor- 
phyrinogen (2) [9,10] with rings b, c and d being 
added in sequence. 
Studies with the enzyme from Rhodopseudo- 
monas sphaeroides have established that a covalent 
bond is formed between the enzyme and the first 
bound substrate [l 11. The nature of the enzymic 
group involved in the covalent linkage with ring a 
has been a matter of great interest. Lysine has been 
favoured by Battersby et al. [12] on the basis of 13C 
NMR experiments and binding studies with 
pyridoxal phosphate [13]. It has also been sug- 
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gested that the SH group of cysteine is 
with the binding of the substrate [14]. 
In this paper we present preliminary 
involved 
evidence 
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that a completely unsuspected and novel enzyme 
bound cofactor, in the form of a dipyrromethane, 
is responsible for the binding of the substrate and 
for directing the synthesis of the tetrapyrrole at the 
catalytic site. 
2. EXPERIMENTAL 
2.1. Materials 
Porphobilinogen and [3,5-14Cz]porphobilinogen 
were prepared as in [ 111. 5-Amino-[5-‘4C]levulinic 
acid was purchased from New England Nuclear 
(Southampton, England). All other chemicals were 
from BDH Chemicals (Poole, Dorset). 
Porphobilinogen deaminase was purified from 
E. coli ST1048 as described in [6]. This strain con- 
tains the plasmid pST48, a pBR322 derivative har- 
bouring the hemC gene and produces almost 100 
times the deaminase compared to the wild type. 
Purified enzyme was stored at - 20°C. Enzyme ac- 
tivity and protein were determined as described [8]. 
The purified enzyme had a specific activity of 
43 pmol/h per mg. 
Porphobilinogen deaminase, in which the dipyr- 
romethane cofactor was labelled with 14C, was 
prepared from bacteria which had been grown in 
the presence of 5-amino[5-14C]levulinic acid 
(20 &i/l). 
2.2. Spectroscopic measurements and reagents 
Calorimetric and spectroscopic measurements 
were carried out at room temperature using a Pye 
Unicam SP8-400 UV/VIS spectrophotometer. 
Ehrlich’s reagent was prepared as in [15]. 
2.3. Formation and isolation of porphobilinogen 
deaminase intermediate complexes 
Enzyme (1 mg, 30 nmol) and porphobilinogen 
(60 nmol) were mixed in a rapid mixing device con- 
sisting of two l-ml syringes linked by a Y-shaped 
tube. The enzyme and enzyme intermediate com- 
plexes were isolated either by electrophoresis as 
described in [8] or by high-resolution ion-exchange 
chromatography using a Pharmacia FPLC system. 
Application of the enzyme to a MonoQ HR 515 
column in 10 mM Tris-HCl buffer, pH 7.5, 
followed by a linear gradient of NaCl permitted 
separation of the enzyme and enzyme intermediate 
complexes which eluted in well separated peaks in 
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the order E, ES, ES2 and ES3 between 0.2 M and 
0.3 M salt. 
3. RESULTS AND DISCUSSION 
3.1. Removal of the bound substrate and isolation 
of the ‘holoenzyme’ 
It is now well established that the addition of the 
substrate porphobilinogen to the deaminase en- 
zyme leads to the formation of stable enzyme in- 
termediate complexes with one (ES), two (ES2) and 
three (ESJ) substrate molecules bound covalently 
at the active site [B]. The bound substrates can be 
removed readily with hydroxylamine (0.2 M) 
which regenerates free enzyme [l 11. This process 
can also be performed by heating the enzyme to 
60°C for 5 min. 
The effectiveness of these treatments for the 
removal of bound substrate was confirmed by first 
incubating the enzyme with [3,5-14C2]por- 
phobilinogen (spec. act. 1 ,&i/90 nmol) to yield 
14C-labelled ES, ES2 and ES3 intermediate com- 
plexes. Treatment of any of these complexes with 
either hydroxylamine or by heating released all the 
bound 14C-label and regenerated the fully active 
enzyme. A typical experiment in which [‘4C]ES2 
(1540 x lo3 dpm/mg) was treated with hydrox- 
ylamine yielded active enzyme with less than 0.1% 
of the radioactivity remaining (1.03 x 
lo3 dpm/mg). Treatment with hydroxylamine also 
released the 14C-label from “C-labelled ES and 
ES3 complexes. The enzyme generated from ES, 
ES2 or ES3 exhibited the same specific activity 
(43 pmol/h per mg) as the purified enzyme. The 
enzyme thus free of substrates is termed the 
holoenzyme. 
3.2. Spectral properties of the enzyme 
The purified holoenzyme is faint light orange- 
yellow in colour with weak absorption bands of 
410 nm and 500 nm (fig.la) at pH 8. 
Acidification of the holoenzyme to pH 3.5 leads 
to a dramatic colour change, the solution turning 
to an intense pink-red colour. The deaminase is ir- 
reversibly inactivated by this process. The absorp- 
tion spectrum of the deaminase at pH 3.5 is very 
different with a large absorption maximum at 
490 nm (fig.lb). 
Similar observations have been made with 
crystals of the enzyme: crystals grown in acid buf- 
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Fig.1. Spectra of porphobilinogen deaminase holoenzyme at (a) pH 8.0 in Tris-HCl buffer, (b) at pH 3.5 in acetate 
buffer, (c) after treatment with formic acid (lo%, v/v), (d) after reaction with Ehrlich’s reagent for 1 min (-) and 
15 min (---). 
fers are pink in colour, whereas those grown at 
higher pH are a pale straw colour. These findings 
suggested the presence of a prosthetic group which 
is protonated to give a pink chromophore under 
acid conditions but which at neutral pH is almost 
colourless (5). 
When the holoenzyme was subjected to treat- 
ment with acid (10% HCOOH, v/v), over a period 
of an hour, a strong absorption maximum 
developed at 405 nm characteristic of a porphyrin 
and the peak at 490 nm declined (fig.lc). Under 
long wavelength ultraviolet light, this solution ex- 
hibited a strong pink fluorescence also indicative 
of the presence of a porphyrin. The nature of the 
porphyrin was unambiguously determined by 
HPLC using a reverse-phase Cl8 column 
developed with sodium phosphate buffer, pH 7.5, 
containing 4% (v/v) acetonitrile [ 161. Comparison 
with authentic standards established that the por- 
phyrin formed was uroporphyrin I (4). The 
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uroporphyrin I was not associated with the enzyme 
protein since after precipitation with trichloro- 
acetic acid (lo%, w/v) followed by centrifugation 
it remained in the supernatant. 
It is well established that, under acid conditions, 
porphyrins are formed from pyrromethanes, first 
by their polymerization to porphyrinogens which 
are then rapidly oxidized to their respective por- 
phyrins. Our observations are thus consistent with 
the presence of a dipyrromethane bound to the 
porphobilinogen deaminase. Furthermore, the 
ability to form uroporphyrinogen I establishes that 
the dipyrromethane is made up of pyrrole units 
similar in structure to that present in por- 
phobilinogens (1). 
3.3. Properties of the bound prosthetic group 
The likelihood that we were observing .a dipyr- 
romethane prompted us to treat the holoenzyme 
with Ehrlich’s reagent, which gives a characteristic 
colour reaction with such compounds [ 171. The in- 
itial reaction of the enzyme with Ehrlich’s reagent 
yielded an intense purple colour over a period of 
30 s, with an absorption maximum at 566 nm. 
This colour quickly faded over a period of 15 min 
to an orange-yellow colour with a new absorption 
maximum at 495 nm. Such spectroscopic 
behaviour is also very strong evidence for the 
presence of a dipyrromethane [17]. The reaction 
with Ehrlich’s reagent also demonstrates that the 
dipyrrole has a free a-position, the significance of 
which will be discussed below. From the foregoing 
information it is clear that the dipyrromethane is 
tightly bound to the porphobilinogen deaminase 
under both weakly basic or weakly acidic condi- 
tions. Stronger acid treatment leads to the libera- 
tion of the pyrromethane and its rapid 
polymerization. 
In an attempt o isolate the dipyrromethane, the 
porphobilinogen deaminase was exhaustively 
digested with pronase. The digest was then 
separated by TLC under acidic conditions 
(butanol/acetic acid/water, 5 : 1: 1, v/v). The com- 
pound migrated as a faint pink band (Rr 0.70) 
which reacted rapidly with Ehrlich’s reagent to 
give an immediate purple colour changing to 
yellow-orange after 5 min. The behaviour of the 
isolated material with Ehrlich’s reagent was 
therefore similar to that of the enzyme bound 
species. 
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The oxidation state of the prosthetic group is 
likely to be that of a dipyrromethane rather than a 
dipyrromethene since prior reduction of the 
holoenzyme with 12 not only inhibited the Ehrlich’s 
reaction but also diminished the yield of porphyrin 
on treatment with formic acid. 
3.4. Mechanistic significance of the 
dipyrromethane 
The evidence described above points to the 
structure of the prosthetic group as being a tightly 
bound dipyrromethane (5) formed from two 
molecules of the substrate. In the presence of acid, 
we suggest hat the enzyme bound dipyrromethane 
is cleaved and rapidly converted into uropor- 
phyrinogen I (4). We believe that this dipyrrole 
represents part of the catalytic site of the por- 
phobilinogen deaminase and that the tetrapyrrole 
product is assembled whilst bound covalently to 
the free a-position of the bound dipyrromethane 
through the sequence (5) - (6)- (7)--+ (8)+ 
(9)- (2). 
A crucial test for this hypothesis is that the ES2 
complex (7) should be shown to contain a tetrapyr- 
role structure composed of the dipyrromethane 
from the holoenzyme linked to the dipyrromethane 
generated from the binding of two substrate 
molecules (rings a and b). Accordingly, the ES2 
complex was generated, purified by FPLC and 
treated with Ehrlich’s reagent. A very rapid reac- 
tion occurred characteristic of a tetrapyr- 
romethane [181. This is similar to the profile shown 
in fig. Id except that the transition from 566 nm to 
495 nm occurs about lo-times faster. 
The existence of a bound tetrapyrrole was fur- 
ther substantiated by formic acid treatment of the 
ES2 intermediate complex which gave twice the 
yield of uroporphyrin I and at a far more rapid 
rate than did the holoenzyme under the same con- 
ditions. We conclude therefore that treatment of 
the ES2 complex with formic acid also releases pyr- 
romethanes, which react spontaneously to yield 
uroporphyrinogen I. This lends further support to 
the suggestion above that the prosthetic group ac- 
tually represents an active site dipyrromethane 
cofactor responsible for binding covalently the 
growing pyrrole chain. It is important to recognize 
that the dipyrromethane of the holoenzyme is not 
exchangeable with substrate under normal condi- 
tions of pH and that it is not released with hydrox- 
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ylamine in sharp contrast to the bound substrates 
(rings a and b in structure 7). 
One as yet unanswered question relates to the 
mechanism by which the dipyrromethane cofactor 
is synthesised and whether this is catalysed by the 
deaminase molecule to which it is ultimately 
bound. A partial answer to this question has come 
from preliminary experiments in which bacteria 
were grown in the presence of S-amino- 
[5-i4C]levulinic acid. This led to the exclusive 
labelling of the porphobilinogen deaminase with 
14C radioactivity, suggesting that the dipyr- 
romethane cofactor is incorporated into the en- 
zyme during the biosynthesis of the proteins. The 
14C-labelled enzyme does not release radioactivity 
when catalysing its reaction, however on treatment 
with formic acid as described above there is a 
stoichiometric release of 14C radioactivity, accom- 
panied by the formation of [14C]uroporphyrin I.
It is hoped that the precise role of the dipyr- 
romethane cofactor will be revealed when the X- 
ray structure of the enzyme is solved, nevertheless 
it is tempting to postulate that an active site dipyr- 
romethane could serve as a ‘moving arm’ on which 
the growing tetrapyrrole can be covalently held as 
the sequential condensations with successive 
substrate molecules occur. The existence of such 
‘moving arms’ is well substantiated in enzymes 
such as fatty acid synthase [19] and pyruvate 
dehydrogenase [20]. However, this is the first 
evidence to suggest a dipyrromethane cofactor as a 
means for manipulating the bound substrate at the 
active site of an enzyme. 
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